X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with AANJANEYA LIFECARE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs DR. DATSONS LABS - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB DR. DATSONS LABS UNICHEM LAB/
DR. DATSONS LABS
 
P/E (TTM) x 32.8 -10.9 - View Chart
P/BV x 3.5 0.2 2,127.9% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 UNICHEM LAB   DR. DATSONS LABS
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
DR. DATSONS LABS
Mar-14
UNICHEM LAB/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs334126 265.9%   
Low Rs17431 563.1%   
Sales per share (Unadj.) Rs146.9133.0 110.5%  
Earnings per share (Unadj.) Rs11.90.2 7,844.7%  
Cash flow per share (Unadj.) Rs16.26.6 245.0%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs105.1128.8 81.6%  
Shares outstanding (eoy) m90.8431.66 286.9%   
Bonus/Rights/Conversions ESOPFCCB-  
Price / Sales ratio x1.70.6 293.8%   
Avg P/E ratio x21.4516.1 4.1%  
P/CF ratio (eoy) x15.711.8 132.5%  
Price / Book Value ratio x2.40.6 397.7%  
Dividend payout %16.80-   
Avg Mkt Cap Rs m23,0732,477 931.4%   
No. of employees `0005.7NA-   
Total wages/salary Rs m2,55856 4,567.8%   
Avg. sales/employee Rs Th2,352.5NM-  
Avg. wages/employee Rs Th450.9NM-  
Avg. net profit/employee Rs Th190.4NM-  
INCOME DATA
Net Sales Rs m13,3464,211 317.0%  
Other income Rs m19279 243.8%   
Total revenues Rs m13,5384,289 315.6%   
Gross profit Rs m1,639569 288.3%  
Depreciation Rs m390204 190.8%   
Interest Rs m29430 6.7%   
Profit before tax Rs m1,41213 11,118.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m-4-2 205.6%   
Extraordinary Inc (Exp) Rs m-350-   
Tax Rs m2936 4,798.4%   
Profit after tax Rs m1,0805 22,508.3%  
Gross profit margin %12.313.5 90.9%  
Effective tax rate %20.748.0 43.2%   
Net profit margin %8.10.1 7,101.3%  
BALANCE SHEET DATA
Current assets Rs m5,9796,852 87.3%   
Current liabilities Rs m2,4326,711 36.2%   
Net working cap to sales %26.63.3 793.8%  
Current ratio x2.51.0 240.8%  
Inventory Days Days63161 39.2%  
Debtors Days Days60318 19.0%  
Net fixed assets Rs m6,4033,673 174.3%   
Share capital Rs m182317 57.4%   
"Free" reserves Rs m9,2933,761 247.1%   
Net worth Rs m9,5484,078 234.2%   
Long term debt Rs m2301,671 13.8%   
Total assets Rs m12,84312,633 101.7%  
Interest coverage x50.01.0 4,859.7%   
Debt to equity ratio x00.4 5.9%  
Sales to assets ratio x1.00.3 311.8%   
Return on assets %8.63.4 250.8%  
Return on equity %11.30.1 9,611.8%  
Return on capital %14.37.7 186.8%  
Exports to sales %29.222.9 127.6%   
Imports to sales %6.314.3 44.4%   
Exports (fob) Rs m3,900964 404.5%   
Imports (cif) Rs m847602 140.7%   
Fx inflow Rs m4,356964 451.9%   
Fx outflow Rs m1,162607 191.5%   
Net fx Rs m3,194357 895.0%   
CASH FLOW
From Operations Rs m1,1191,345 83.2%  
From Investments Rs m-853-2,256 37.8%  
From Financial Activity Rs m-334-1,200 27.9%  
Net Cashflow Rs m-68-2,111 3.2%  

Share Holding

Indian Promoters % 50.1 4.5 1,106.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 0.0 -  
FIIs % 3.0 1.4 222.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 94.1 33.7%  
Shareholders   20,176 20,807 97.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   BIOCON LTD  CADILA HEALTHCARE  VENUS REMEDIES  PLETHICO PHARMA  WOCKHARDT LTD.  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jan 19, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS